Aug. 2, 2002 -- Prophylactic intrathecal methotrexate significantly reduced recurrence and improved survival for patients in complete remission from aggressive non-Hodgkin's lymphoma (NHL), according ...
“Trying to Be a Good Parent” As Defined By Interviews With Parents Who Made Phase I, Terminal Care, and Resuscitation Decisions for Their Children In this multisite study, 171 children with ...
Childhood cancer survivors have an elevated lifetime risk for meningioma, with the greatest risks among those who received ...
Between 1993 and 1999, 1395 children with ALL (778 boys, 617 girls) were enrolled in the FRALLE 93 study. Informed consent was obtained from all patients’ parents in accordance with national ethic ...
The purpose of this study was to determine the incidence of and pharmacokinetic parameters associated with the development of transient encephalopathy following the administration of high-dose ...
Accord Healthcare, a London-based drugmaker, resumed manufacturing of two methotrexate solutions, according to a Nov. 7 update from the FDA. By March, the American Society of Health-System Pharmacists ...
Up to three quarters of patients receiving cancer chemotherapy suffer from "chemo brain" - a long-term side effect that makes it harder to remember things, maintain attention, and learn new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback